Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains
- 11 June 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (11), 5816-5840
- https://doi.org/10.1021/acs.jmedchem.0c00075
Abstract
Non-BET bromodomain-containing proteins have become attractive targets for the development of novel therapeutics targeting epigenetic pathways. To help facilitate the target validation of this class of proteins, structurally diverse small-molecule ligands and methodologies to produce selective inhibitors in a predictable fashion are in high demand. Herein, we report the development and application of atypical acetyl-lysine (KAc) methyl mimetics to take advantage of the differential stability of conserved water molecules in the bromodomain binding site. Discovery of the n-butyl group as an atypical KAc methyl mimetic allowed generation of 31 (GSK6776) as a soluble, permeable, and selective BRD7/9 inhibitor from a pyridazinone template. The nbutyl group was then used to enhance the bromodomain selectivity of an existing BRD9 inhibitor and to transform panbromodomain inhibitors into BRD7/9 selective compounds. Finally, a solvent-exposed vector was defined from the pyridazinone template to enable bifunctional molecule synthesis, and affinity enrichment chemoproteomic experiments were used to confirm several of the endogenous protein partners of BRD7 and BRD9, which form part of the chromatin remodeling PBAF and BAF complexes, respectively.Funding Information
- Research Councils UK (EP/S035990/1)
- GlaxoSmithKline
- University of Strathclyde
This publication has 51 references indexed in Scilit:
- Identification of driver genes in hepatocellular carcinoma by exome sequencingHepatology, 2013
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- Target validation using chemical probesNature Chemical Biology, 2013
- The Spectrum of SWI/SNF Mutations, Ubiquitous in Human CancersPLOS ONE, 2013
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Bromodomains as therapeutic targetsExpert Reviews in Molecular Medicine, 2011
- Interaction of Propionylated and Butyrylated Histone H3 Lysine Marks with Brd4 BromodomainsAngewandte Chemie, 2010
- BRD7 is a candidate tumour suppressor gene required for p53 functionNature, 2010
- The art of the chemical probeNature Chemical Biology, 2010
- A crowdsourcing evaluation of the NIH chemical probesNature Chemical Biology, 2009